Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- The team shrank two years in a row.
- Little cash and receivables against the short-term debts.
Revenue
€ 35.3 million
▲ 1% vs 2024
Profit
Caution€ -14.4 million
▼ 37% vs 2024
Debts
High€ 267.4 million
▲ 32% vs 2024
Ceres Pharma from Gent, company number BE0641953324, closed financial year 2025 with a result of € -14.4 million after tax. For that financial year Ceres Pharma recorded revenue of € 35.3 million and equity of € -1.6 million. Compared with financial year 2024, the result moved from € -10.5 million to € -14.4 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
What happened at Ceres Pharma?
What happened at Ceres Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Ceres Invest BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 14.4 million. Source: NBB ↗
- Ceres Invest BV became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 2.6 million loss in 2021 to € 14.4 million loss in 2025.
Paid € 79,820 in corporate taxes since 2021.
A new publication or filing at Ceres Pharma? We notify you, reason included.
Follow Ceres PharmaNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Ceres Invest BV (100%). It owns 100% of Ceres Pharma Serbia doo, 100% of Dacia Plant, 100% of Vesale Pharma, 100% of Ceres Pharma Slovakia SRO, 100% of Technokom Trade EOOD and 100% of Ceumed s.r.o.CZ itself.
Directors
According to the 2025 annual accounts
Director · represented by Mario Debel
since 2021 · until 2027
Shareholders
100%
Participations
Ceres Pharma Serbia doo
100%
Dacia Plant
100%
100%
Ceres Pharma Slovakia SRO
100%
100%
Ceumed s.r.o.CZ
100%
100%
100%
100%
100%
100%
100%
Ceres Pharma Italy SRL
100%
100%
Ceres Pharma Hungary Kft.
100%
Ceres Pharma Romania
100%
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1091 box B
9051 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
Ceres Pharmaceuticals same network
€ 14.6 million revenue · 2025
What's Cooking Group
KOUTERLOS
€ 55,337 gross margin · 2024
b+pharma Belgium
€ 287,023 gross margin · 2025
DGPharma
€ 94,120 gross margin · 2024
+15 more
Details
- Company number
- 0641.953.324
- VAT number
- BE 0641.953.324
- Registered office
- Kortrijksesteenweg 1091 bus B, 9051 Gent
- Names & denominations
- Ceres Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 October 2015
- Peppol
- Active · Active since 26 Aug 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van andere voedingsmiddelen, neg
Overige detailhandel in voedingsmiddelen, neg
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.